Company Filing History:
Years Active: 2001-2009
Title: Lihsyng Standford Lee: Innovator in Polypeptide Modification
Introduction
Lihsyng Standford Lee is a notable inventor based in Princeton Junction, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the modification of polypeptides. With a total of six patents to his name, his work has implications for therapeutic applications.
Latest Patents
One of his latest patents focuses on polyalkylene oxide-modified single chain polypeptides. This invention involves the chemical modification of single chain polypeptides through the covalent attachment of strands of poly(ethylene glycol) (PEG) and similar poly(alkylene oxides). These modified polypeptides exhibit reduced immunogenicity and antigenicity, along with a longer half-life in the bloodstream compared to their parent polypeptides. Such properties enhance their utility in various therapeutic applications. The invention also encompasses multivalent antigen-binding molecules capable of PEGylation, along with compositions, genetic constructions, methods of use, and production techniques for PEGylated antigen-binding proteins.
Career Highlights
Lihsyng Standford Lee has had a distinguished career, primarily working with Enzon, Inc. His innovative approaches to polypeptide modification have positioned him as a key figure in the biopharmaceutical industry. His research has paved the way for advancements in therapeutic treatments.
Collaborations
Throughout his career, Lihsyng has collaborated with notable colleagues, including David R. Filpula and Marc D. Whitlow. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
Lihsyng Standford Lee's work in the modification of polypeptides has made a significant impact in the field of biochemistry. His innovative patents and collaborations highlight his dedication to advancing therapeutic applications.